Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 160

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 1
Chunk 160
---
 SEC rules, which includes the individuals indicated in the table below for each fiscal year:

87

    Year
     
    PEO
     
    Non-PEO NEOs
  
    2024
     
    Jeffrey A. Meckler
     
    Walt A. Linscott, Esq. and Roger Waltzman M.D.
  
    2023
     
    Jeffrey A. Meckler
     
    Walt A. Linscott, Esq. and Michael J. Newman, Ph.D.
  
    2022
     
    Jeffrey A. Meckler
     
    Walt A. Linscott, Esq. and Boyan Litchev, M.D.

The
amounts reported in the “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to Non-PEO NEOs”
columns do not reflect the actual compensation paid to or realized by our PEO or our non-PEO NEOs during each applicable year. The calculation
of compensation actually paid for purposes of this table includes point-in-time fair values of stock awards and these values will fluctuate
based on our stock price and various accounting valuation assumptions. See the Summary Compensation Table for certain other compensation
of our PEO and our non-PEO NEOs for each applicable fiscal year.

Compensation
actually paid to our NEOs represents the “Total” compensation reported in the Summary Compensation Table for the applicable
fiscal year, as adjusted as follows:

    2024 
  
    Adjustments 
    PEO  
    Average non-PEO NEOs 
  
    Deduction for Amounts Reported under the “Stock Awards” and “Option Awards” Columns in the Summary Compensation Table for Applicable FY 
    $(219,421) 
    $(182,156)

    Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Remain Unvested as of Applicable FY End, determined as of Applicable FY End 
     123,369  
     106,209 

    Decrease for Awards Granted during Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End 
     (46,684) 
     (29,455)

    Increase for Awards Granted during Prior FY that Vested During Applicable FY, determined based on change in ASC 718 Fair Value from Prior